Cover Image

Dynamics of HIV PrEP use and coverage during and after COVID-19 in Germany

Abstract Background Pre-exposure prophylaxis (PrEP) with oral emtricitabine/tenofovir disoproxil (FTC/TDF) proved highly efficient in preventing HIV. Since 09/2019, FTC/TDF-PrEP is covered by health insurances in Germany, if prescribed by licensed specialists. However, methods to longitudinally moni...

Full description

Saved in:

Bibliographic Details
Main Authors:	Daniel Schmidt (Author), Yannick Duport (Author), Christian Kollan (Author), Ulrich Marcus (Author), Sara Iannuzzi (Author), Max von Kleist (Author)
Format:	Book
Published:	BMC, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
by: Uwe Koppe, et al.
Published: (2021)

"PrEP"ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women
by: Elizabeth C. Pasipanodya, et al.
Published: (2021)

Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement
by: Patrick Ahaus, et al.
Published: (2022)

Oral PrEP for HIV prevention. It works
by: Erica Pool, et al.
Published: (2015)

Centering PrEP: Utilizing ADAPT-ITT to inform group PrEP care for sex workers in Chicago
by: Randi Beth Singer, et al.
Published: (2024)

Chemsex on PrEP: risk behaviours and STI incidence among PrEP patients using illicit substances
by: Zoë Greenwald, et al.
Published: (2018)

PrEP in Europe: where are we?
by: Rosalind Coleman
Published: (2018)

Cost effectiveness of PrEP in Europe
by: Brooke Nichols
Published: (2018)

Correlations between oral Pre-Exposure Prophylaxis (PrEP) initiations and policies that enable the use of PrEP to address HIV globally.
by: Janki Tailor, et al.
Published: (2022)

Correlations between oral Pre-Exposure Prophylaxis (PrEP) initiations and policies that enable the use of PrEP to address HIV globally
by: Janki Tailor, et al.
Published: (2022)

HIV PrEP opens the door to STDs. The cons
by: Mark Wainberg
Published: (2016)

Patterns of PrEP and condom use among PrEP users in Belgium: a web-based longitudinal study
by: Anke Rotsaert, et al.
Published: (2023)

Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs
by: Angela R. Bazzi, et al.
Published: (2023)

Need for informed providers: exploring LA-PrEP access in focus groups with PrEP-indicated communities in Baltimore, Maryland
by: Rose Pollard Kaptchuk, et al.
Published: (2024)

HIV PrEP Coverage Among Black Adults: A Concept Analysis of the Inequities, Disparities, and Implications
by: Ikenna Obasi Odii, et al.
Published: (2024)

Navigating patterns of oral PrEP use: A qualitative longitudinal study of gay, bisexual, and queer men's dynamic practices of pausing, on-demand, and stopping PrEP in Canada
by: Emerich Daroya, et al.
Published: (2024)

Fanconi Syndrome Induced by Concomitant HIV PrEP and Tacrolimus
by: Becky S. Linn PharmD, et al.
Published: (2021)

Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the "PrEP as a bridge to ART" strategy
by: Nicholas Musinguzi, et al.
Published: (2020)

The relationship of PrEP beliefs to perceived personal, interpersonal and structural benefits and barriers to PrEP use in women who inject drugs
by: Kirsten Paulus, et al.
Published: (2023)

Acceptability of six-monthly PrEP dispensing supported with interim HIV self-testing to simplify PrEP delivery in Kenya: findings from qualitative research
by: Nicholas Thuo, et al.
Published: (2024)

PrEP use and unmet PrEP-need among men who have sex with men in London prior to the implementation of a national PrEP programme, a cross-sectional study from June to August 2019
by: Dana Ogaz, et al.
Published: (2022)

What motivated men to start PrEP? A cross-section of men starting PrEP in Buffalo city municipality, South Africa
by: Philip John Smith, et al.
Published: (2023)

Addressing disparities in Pre-exposure Prophylaxis (PrEP) access: implementing a community-centered mobile PrEP program in South Florida
by: Stefani A. Butts, et al.
Published: (2023)

Pre-Exposure Prophylaxis (PrEP) Awareness Is Low Among Heterosexual People of Color Who Might Benefit From PrEP in Philadelphia
by: Alexis M. Roth, et al.
Published: (2019)

Understanding characteristics of daily and on-demand PrEP prescriptions
by: Zoë Greenwald, et al.
Published: (2018)

Misuse of PrEP and atypical HIV seroconversion: about a case
by: Hélène Laroche, et al.
Published: (2018)

How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP
by: Victoria Pilkington, et al.
Published: (2018)

Identifying patterns of sexual behaviors and PrEP uptake characteristics among MSM who were eligible for PrEP: A national cross-section study
by: Yuanyuan Liu, et al.
Published: (2024)

Creating allies: qualitative exploration of young women's preferences for PrEP methods and parents' role in PrEP uptake and user support in urban and rural Zambia
by: Christina Misa Wong, et al.
Published: (2024)

Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: a population-based analysisResearch in context
by: Patrick S. Sullivan, et al.
Published: (2024)

The PrEP recommendation: the inscribed disease in a healthy body
by: Simone Wolfgang, et al.
Published: (2020)

Expanding Pre-Exposure Prophylaxis (PrEP) Utilization in the Philippine HIV Crisis
by: Rowalt Alibudbud
Published: (2023)

Knowledge of PEP and PrEP among people living with HIV/aids in Brazil
by: Laelson Rochelle Milanês Sousa, et al.
Published: (2021)

Women at high risk of HIV-infection in Kampala, Uganda, and their candidacy for PrEP
by: Rachel Kawuma, et al.
Published: (2021)

Knowledge and perceptions of HIV Pre-exposure Prophylaxis (PrEP) among patients
by: Yvette Calderon, et al.
Published: (2016)

Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties
by: Santiago Moreno Guillen, et al.
Published: (2017)

Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) therapy for HIV prevention
by: Clauson KA, et al.
Published: (2009)

Barriers to Pre-Exposure Prophylaxis (PrEP) use for HIV: an integrative review
by: Marcela Antonini, et al.
Published: (2023)

Not PrEPared to wait any longer: advocating for the use of PrEP in a HIV prevention strategy
by: Nicklas Brown
Published: (2017)

HIV Pre‐Exposure Prophylaxis (PrEP) Users' Experiences of PrEP Access, Sexual Behaviour, and Well‐Being During the COVID‐19 Pandemic: A Welsh Qualitative Study
by: Zahraa Khammas, et al.
Published: (2024)